[Evaluation of drug efficacy for preventing paroxysmal atrial fibrillation].
Fujiki
A
A
Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University.
Yoshida
S
S
Tani
M
M
Sasayama
S
S
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000517:prevention & control*; D002304:Cardiac Pacing, Artificial; D004206:Disopyramide / Q000008:administration & dosage*; D004341:Drug Evaluation; D015716:Electrocardiography, Ambulatory; D004594:Electrophysiology; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000008:administration & dosage*
D004206:Disopyramide; D011342:Procainamide